… for central visual acuity (VA) concerning drug approvals. Central subfield thickness does
correlate … after a period of treatment, but correlations have been surprisingly low, usually in the …

… The aim of this study was to evaluate the correlation between the central macular
thickness (CMT) using OCT and best-corrected visual acuity in diabetic macular edema. …

… macular thickness might be for clinically significant DMO and how this is related to VA. The
assessment of this relationship … how well a change in macular thickness could be a predictor …

… ; the central subfield macular thickness and macular volume were … central subfield macular
thickness, and macular volume changes after treatment of DME. The thickness of outer retinal …

… macular thickness in normal individuals was (224.61 ± 8.8 μm). The authors found that the
mean macular thickness of the diabetic … in thickness compared with the control (P < 0.001). …

… of diabetes which significantly accounts for preventable visual impairment and blindness.
Central macular thickness (CMT) … This study aims to determine the relationship between optical …

… Assessment of macular thickness, readily available via central subfield … the relationship
between BCVA and CST in patients with ME resulting from retinal vein occlusion (RVO), diabetic …

… shown that visual acuity in patients with macular edema can … inverse relationship between
macular thickness and macular … for every 10% deviation in retinal thickness from the normal …

… , and DRIL were associated with significantly lower final visual acuity (p<0.0001), while
there was no relationship between pre-treatment SD and final visual acuity (p=0.11). Injection …

… Relationship between optical coherence … macular thickening following intravitreous
aflibercept, bevacizumab, or ranibizumab for central-involved diabetic macular edema with vision …